Government Affairs
644 Massachusetts Avenue NE Suite 505 Washington DC 20002, Washington, DC · SEAN TODD
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2017 | APTIM |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$15,000 | — | |
| 2017 | APTIM |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$15,000 | — | |
| 2017 | FUSRAP COALITION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report (No Activity) |
— | — | |
| 2017 | SOAR FOUNDATION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report (No Activity) |
— | — | |
| 2017 | PRO2SERV |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$20,000 | — | |
| 2017 | PERMA-FIX ENVIRONMENTAL SERVICES |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$30,000 | — | |
| 2017 | APTIM |
3rd Quarter (July 1 - Sep 30) Registration |
— | — | |
| 2017 | CB&I, FORMERLY THE SHAW GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination |
$20,000 | — | |
| 2017 | PRO2SERV |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$20,000 | — | |
| 2017 | SOAR FOUNDATION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report (No Activity) |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| PERMA-FIX ENVIRONMENTAL SERVICES | 73 | $2,215,000 |
| CB&I, FORMERLY THE SHAW GROUP | 46 | $850,000 |
| FUSRAP COALITION | 46 | $60,000 |
| HOLTEC INTERNATIONAL | 36 | $75,000 |
| VINMAR INTERNATIONAL | 21 | $440,000 |
| ACUMENTRICS CORPORATION | 19 | $290,000 |
| IMPACT SERVICES, INC | 15 | $341,000 |
| QUANTUMSPHERE, INC | 15 | $130,000 |
| COAL SLAG CONSORTIUM (FORMERLY KNOWN AS US MINERALS) | 14 | $130,000 |
| APTIM | 12 | $160,000 |
| THE BABCOCK & WILCOX COMPANY | 10 | $140,000 |
| PRO2SERV | 9 | $90,000 |
| SOAR FOUNDATION | 9 | $10,000 |
| SAIC | 8 | $190,000 |
| AFGHAN MEDICAL RELIEF FOUNDATION | 8 | — |
| TS CONDUCTOR | 7 | $300,000 |
| ELECTRATHERM, INC | 7 | $45,000 |
| ARCHANGEL INC | 7 | $40,000 |
| PIXELLIGENT, LLC | 7 | — |
| VIRENT ENERGY SYSTEMS | 2 | $40,000 |
| Name | Disclosed Prior Position |
|---|---|
| SEAN TODD | President and CEO |